gilead sciences inc
Antiviral Remdesivir: US Approves First Drug to Treat Covid-19, Cuts Recovery Period by 5 Days
One in Three South Korean Covid-19 Patients Improve with Gilead's Antiviral Drug Remdesivir
Gilead Says Additional Data on Remdesivir Shows Improved Clinical Recovery in Covid-19 Patients
Gilead Begins Testing Inhalable Form of Anti-viral Remdesivir for Covid-19
US Group Raises Pricing Recommendation for Gilead's Remdesivir in Covid-19
Covid-19: How Hetero Jumped on to the Remdesivir Bandwagon And Launched COVIFOR
Gilead's Remdesivir Slows Progression of Covid-19, Prevents Lung Damage in Monkeys, Shows Study
India Approves Gilead's Antiviral Drug Remdesivir to Treat Severe Covid-19 Cases
South Korea Approves Emergency Use of Gilead's Anti-viral Drug to Treat Covid-19
Health Groups Ask India to Rescind Gilead's Patents for Covid-19 Drug Remdesivir
Japan Says Drugmaker Gilead's Covid-19 Treatment Remdesivir Now in Use in Hospitals
Japan Says Drugmaker Gilead's Covid-19 Treatment Remdesivir Now in Use in Hospitals
Will Gilead Price its Coronavirus Drug for Public Good or Company Profit?
Fauci Says Leak Concerns Fueled his White House Revelation of Gilead Drug Results
Asian Stocks Set to Track US Gains as Virus Treatment Hopes Lift Confidence
US President Donald Trump, Anthony Fauci See Hope with Gilead'S Drug in Coronavirus Fight
Ten Things You Need to Know about the Drug That May Soon Be Used to Treat COVID-19
